Disc Medicine annual depreciation and amortization
2020
2021
2022
2023
2024
2025
Disc Medicine Depreciation & Amortization Growth & History (IRON)
Disc Medicine's depreciation and amortization was $281,000 for fiscal 2025.
View full Disc Medicine company overviewDisc Medicine annual depreciation and amortization history
| Fiscal year | Period ended | Depreciation and amortization | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $281,000 | $125,000 | +80.13% |
| 2024 | 2024-12-31 | $156,000 | $56,000 | +56.00% |
| 2023 | 2023-12-31 | $100,000 | $11,000 | +12.36% |
| 2022 | 2022-12-31 | $89,000 | $57,000 | +178.13% |
| 2021 | 2021-12-31 | $32,000 | −$290,000 | −90.06% |
| 2020 | 2020-12-31 | $322,000 | — | — |
Disc Medicine quarterly depreciation and amortization
Q1.20
Q2.20
Q3.20
Q1.21
Q2.21
Q3.21
Q1.22
Q2.22
Q3.22
Q1.23
Q2.23
Q3.23
Q1.24
Q2.24
Q3.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Depreciation and amortization | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $90,000 | $5,000 | +5.88% |
| Q1 2026 | 2026-03-31 | $89,000 | $69,000 | +345.00% |
| Q4 2025 | 2025-12-31 | $89,000 | — | — |
| Q3 2025 | 2025-09-30 | $87,000 | $76,000 | +690.91% |
| Q2 2025 | 2025-06-30 | $85,000 | −$25,000 | −22.73% |
| Q1 2025 | 2025-03-31 | $20,000 | −$6,000 | −23.08% |
| Q3 2024 | 2024-09-30 | $11,000 | −$14,000 | −56.00% |
| Q2 2024 | 2024-06-30 | $110,000 | $85,000 | +340.00% |
| Q1 2024 | 2024-03-31 | $26,000 | $1,000 | +4.00% |
| Q3 2023 | 2023-09-30 | $25,000 | $1,000 | +4.17% |
| Q2 2023 | 2023-06-30 | $25,000 | $3,000 | +13.64% |
| Q1 2023 | 2023-03-31 | $25,000 | $7,000 | +38.89% |
| Q3 2022 | 2022-09-30 | $24,000 | −$34,000 | −58.62% |
| Q2 2022 | 2022-06-30 | $22,000 | −$40,000 | −64.52% |
| Q1 2022 | 2022-03-31 | $18,000 | −$47,000 | −72.31% |
| Q3 2021 | 2021-09-30 | $58,000 | −$22,000 | −27.50% |
| Q2 2021 | 2021-06-30 | $62,000 | −$16,000 | −20.51% |
| Q1 2021 | 2021-03-31 | $65,000 | −$12,000 | −15.58% |
| Q3 2020 | 2020-09-30 | $80,000 | — | — |
| Q2 2020 | 2020-06-30 | $78,000 | — | — |
| Q1 2020 | 2020-03-31 | $77,000 | — | — |
Disc Medicine depreciation and amortization trends
Over the last five fiscal years, Disc Medicine's depreciation and amortization decreased from $322,000 to $281,000, a change of −$41,000. The latest reported quarter, Q2 2026, shows $90,000.
About the metric
What depreciation and amortization mean
Depreciation and amortization allocate the cost of tangible and intangible assets over their useful lives. These non-cash expenses reduce reported earnings and are commonly added back when calculating EBITDA and operating cash flow.
Calculation and source
Reported depreciation and amortization
TickerStat uses a combined depreciation and amortization value when reported. If a company reports the two components separately for an aligned period, they are added together without duplicating overlapping facts. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Disc Medicine source filings ↗